WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...

A rare red meat allergy, usually linked to a bite from the lone star tick, may also be caused by other tick species found in ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

unlike other gene-based antibody delivery approaches where ADA formation has been a challenge Well-tolerated: most common side effects were mild, temporary injection site reactions such as pain and ...

Antibody-drug conjugates (ADCs ... revealing biotransformations previously not observed using the traditional LC-MRM (liquid chromatography-multiple reaction monitoring) approach. (8) In this intact ...

Mabylon AG recently provided preclinical data for MY-006, a half-life extended trispecific anti-peanut antibody being developed for the treatment of peanut allergy. Half-life extended trispecific anti ...

In 2020, Sanofi's Sarclisa (isatuximab-irfc), a CD38-directed cytolytic antibody, snared FDA approval ... infusion-related reactions, anemia and thrombocytopenia. One patient died from a TEAE ...